Device Trial Radar · NCT06589310
Falcon Real World Evidence Registry
Last checked: Nov 19, 2026Latest source record: Sep 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
25,000
Planned (sponsor's estimate)
Start
Aug 1, 2024
Primary completion
Aug 2030
Study completion Jan 2031
Sponsor
- Lead sponsor
- Exact Sciences CorporationNot on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 19, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 50 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a multi-site registry of patients receiving the Exact Sciences Multicancer Early Detection (MCED) test.
Conditions
- Cancer
Interventions
Exact Sciences Multicancer Early Detection (MCED) TestDevice
Exact Sciences MCED test, is a qualitative in vitro diagnostic (IVD) for the detection of alterations in circulating tumor DNA and tumor-associated protein levels, which are commonly associated with cancer. It is performed on plasma derived from peripheral blood specimens.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Vital statusTime frame: Up to 5 years
- Cancer statusTime frame: Up to 5 years
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Endeavor Health
Evanston, Illinois · Recruiting
Baylor Scott & White Health
Dallas, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.